Viadur

   
Google
 
Web NewDrugInformation.com

Viadur


Drug - Viadur
The trade name of the product as shown on the labeling.

Dosage - IMPLANT; IMPLANTATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Leuprolide Acetate
Multiple ingredients are in alphabetical order.

Strength - EQ 65MG BASE
The potency of the active ingredient(s), Leuprolide Acetate. May repeat for multiple part products.

Applicant - ALZA
The firm name holding legal responsibility for Viadur. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021088
The FDA assigned number to Viadur. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Viadur. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 3, 2000
The date Viadur was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Viadur. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Viadur is in. Format is RX, OTC, DISCN.

Applicant Full Name - Alza Corp
The full name of the firm holding legal responsibility for the new application of Viadur.

Viadur